Detalhe da pesquisa
1.
Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
Clin Infect Dis
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466720
2.
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med
; 385(4): 320-329, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192428
3.
SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.
MMWR Morb Mortal Wkly Rep
; 73(16): 365-371, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668391
4.
Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
J Immunol
; 208(11): 2461-2465, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562119
5.
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
JAMA
; 331(5): 408-416, 2024 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319331
6.
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses.
Clin Infect Dis
; 76(10): 1822-1831, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36578137
7.
Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals.
Clin Infect Dis
; 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963102
8.
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
Emerg Infect Dis
; 29(3): 599-604, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36703252
9.
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 Pandemic.
Crit Care Med
; 51(4): 445-459, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790189
10.
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies.
Environ Res
; 239(Pt 1): 117297, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816422
11.
Disease and social factors associated with healthcare utilization for the treatment of SARS-CoV-2 infections in a longitudinal cohort of essential workers in Arizona.
BMC Health Serv Res
; 23(1): 1118, 2023 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853403
12.
Household Transmission of Influenza A Viruses in 2021-2022.
JAMA
; 329(6): 482-489, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701144
13.
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection.
Clin Infect Dis
; 75(1): e827-e837, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928334
14.
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 422-428, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298453
15.
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
JAMA
; 328(15): 1523-1533, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255426
16.
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
MMWR Morb Mortal Wkly Rep
; 70(5152): 1761-1765, 2021 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968373
17.
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(13): 495-500, 2021 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793460
18.
Clinical Data Extraction During Public Health Emergencies: A Blockchain Technology Assessment.
Biomed Instrum Technol
; 55(3): 103-111, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460906
19.
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
N Engl J Med
; 386(19): 1855-1857, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385628
20.
Temporal Changes in Vaccine-Specific Willingness Across Race/Ethnicity Following Serious Adverse Event Reports.
Am J Public Health
; 114(S1): S37-S40, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944076